PYRIDOSTIGMINE BROMIDEagainst muscle weakness
SHORT LEAD TIME, COMPETITIVE PRICE
THERAPEUTIC INDICATION: CENTRAL NERVOUS SYSTEM
PYRIDOSTIGMINE BROMIDE is used to treat muscle weakness with myasthenia gravis or forms of congenital myasthenic syndrome.
- GMP: EU, JP, US
- US-DMF: YES
- CEP: YES
- EU-DMF: YES
- COA: EP, USP
- Competitive price
- Short lead time (stock product)
- Batch size: approx. 1.100 kg
This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.